• Bloomberg

  • SHARE

Before a planned trip to the U.S., Cheng wanted to get vaccinated against COVID-19. To do so, he asked a friend working at a cold-chain logistics company in southeast China to pretend he was employed by the firm, allowing Cheng access to one of the country’s experimental shots.

Cheng, a business owner from Beijing, now plans to fly to Guangdong province and pay as much as $91 to take two doses of what he believes is a vaccine being produced by a unit of Sinopharm, the state-backed Chinese developer at the front of the global COVID-19 vaccine race.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)